At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 226 enrolled
Drug / intervention
Bacitracindrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effectiveness of Antibiotic Delivery Via Bio-absorbable Sponge After Functional Endoscopic Sinus Surgery
Steward St. Elizabeth's Medical Center of Boston, Inc.·interventional·Posted Oct 18, 2010·Updated May 31, 2017
In Brief
A Phase 2 clinical trial evaluating Bacitracin for Paranasal Sinus Disease. Completed, enrolled 226 participants across 1 site.
Detailed Summary
This study will evaluate the efficacy of a nasopore sponge dressing soaked in Bacitracin VS a sponge soaked in Saline / and the administration of oral antibiotics.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParanasal Sinus Disease
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2010
First PostedOct 2010
Primary CompletionJun 2012
TodayJul 2026
First PostedOct 18, 2010
Enrollment StartJul 1, 2010
Primary CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 15.7 years ago
Interventions
Bacitracindrug
Bacitracin soaked nasopore sponge